International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines

Dodd, Caitlin N.... et al.Global H1N1 GBS ConsortiumMarshall, Helen Siobhan2014-02-042014-02-042013Vaccine, 2013; 31(40):4448-58http://hdl.handle.net/2440/81907Global H1N1 GBS Consortium contributor: Helen MarshallCopyright © 2013 Elsevier Ltd.Guillain Barré Syndrome (GBS); Monovalent H1N1 Vaccine (H1N1); Self-controlled case-series method (SCCS); International; Adjuvant; Adverse events following immunization (AEFI)International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccinesInternational collaboration to assess the risk of Guillain Barre Syndrome following Influenza A (H1N1) 2009 monovalent vaccinesJournal article2014020413153810.1016/j.vaccine.2013.06.03292 Health9204 Public Health (excl. Specific Population Health)920404 Disease Distribution and Transmission (incl. Surveillance and Response)11 Medical and Health Sciences1114 Paediatrics and Reproductive Medicine111403 Paediatrics